Nanotechnology enables rapid detection and targeted treatments for urinary tract infections, suggesting improved patient outcomes.
Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting millions annually and imposing significant healthcare costs. Rising antibiotic resistance among uropathogens coupled with the limitations of culture-based diagnostics and systemic therapies demands innovative approaches. Nanotechnology offers transformative potential, enabling rapid, point of care (POC) detection and targeted antimicrobial interventions that promise to outperform evolving resistance mechanisms.
No takes yet. Share an insight, caveat, or question.
Krishna et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: